Aim: The aim of this study is to comparatively evaluate the serum and salivary high-sensitive C-reactive protein (hs-CRP) in patients with acute myocardial infarction (MI).
Subjects And Methods: The study group consisted of 60 patients of whom 30 were MI patients and 30 were controls. Serum hs-CRP was assessed using particle-enhanced immunoturbidimetric assay. Saliva hs-CRP is determined using a microplate reader cum UV photospectrometer from BMG.
Results: In this study, levels of both serum and salivary hs-CRP in control and MI patients showed a positive correlation. Saliva can be used as an alternative biofluid to determine hs-CRP in MI patients.
Conclusion: Saliva can be used as a alternative biofluid to determine the risk as well as to determine prognosis in acute myocardial infarction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469396 | PMC |
http://dx.doi.org/10.4103/jpbs.jpbs_845_21 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!